Titre : Gonades

Gonades : Questions médicales fréquentes

Termes MeSH sélectionnés :

Probability
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Gonades : Questions médicales les plus fréquentes", "headline": "Gonades : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Gonades : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-31", "dateModified": "2025-04-27", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Gonades" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Glandes endocrines", "url": "https://questionsmedicales.fr/mesh/D004702", "about": { "@type": "MedicalCondition", "name": "Glandes endocrines", "code": { "@type": "MedicalCode", "code": "D004702", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A06.300" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Ovaire", "alternateName": "Ovary", "url": "https://questionsmedicales.fr/mesh/D010053", "about": { "@type": "MedicalCondition", "name": "Ovaire", "code": { "@type": "MedicalCode", "code": "D010053", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A06.300.312.497" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Corps jaune", "alternateName": "Corpus Luteum", "url": "https://questionsmedicales.fr/mesh/D003338", "about": { "@type": "MedicalCondition", "name": "Corps jaune", "code": { "@type": "MedicalCode", "code": "D003338", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A06.300.312.497.278" } } }, { "@type": "MedicalWebPage", "name": "Follicule ovarique", "alternateName": "Ovarian Follicle", "url": "https://questionsmedicales.fr/mesh/D006080", "about": { "@type": "MedicalCondition", "name": "Follicule ovarique", "code": { "@type": "MedicalCode", "code": "D006080", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A06.300.312.497.535" } } } ] }, { "@type": "MedicalWebPage", "name": "Testicule", "alternateName": "Testis", "url": "https://questionsmedicales.fr/mesh/D013737", "about": { "@type": "MedicalCondition", "name": "Testicule", "code": { "@type": "MedicalCode", "code": "D013737", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A06.300.312.782" } } } ], "about": { "@type": "MedicalCondition", "name": "Gonades", "alternateName": "Gonads", "code": { "@type": "MedicalCode", "code": "D006066", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Izabela Rams-Pociecha", "url": "https://questionsmedicales.fr/author/Izabela%20Rams-Pociecha", "affiliation": { "@type": "Organization", "name": "Department of Comparative Anatomy, Institute of Zoology and Biomedical Research, Jagiellonian University, 30-387 Krakow, Poland." } }, { "@type": "Person", "name": "Paulina C Mizia", "url": "https://questionsmedicales.fr/author/Paulina%20C%20Mizia", "affiliation": { "@type": "Organization", "name": "Department of Comparative Anatomy, Institute of Zoology and Biomedical Research, Jagiellonian University, 30-387 Krakow, Poland." } }, { "@type": "Person", "name": "Rafal P Piprek", "url": "https://questionsmedicales.fr/author/Rafal%20P%20Piprek", "affiliation": { "@type": "Organization", "name": "Department of Comparative Anatomy, Institute of Zoology and Biomedical Research, Jagiellonian University, 30-387 Krakow, Poland." } }, { "@type": "Person", "name": "Serge Nef", "url": "https://questionsmedicales.fr/author/Serge%20Nef", "affiliation": { "@type": "Organization", "name": "Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland. Electronic address: serge.nef@unige.ch." } }, { "@type": "Person", "name": "Isabelle Stévant", "url": "https://questionsmedicales.fr/author/Isabelle%20St%C3%A9vant", "affiliation": { "@type": "Organization", "name": "Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Modeling the Probability of HIV Infection over Time in High-Risk Seronegative Participants Receiving Placebo in Five Randomized Double-Blind Placebo-Controlled HIV Pre-Exposure Prophylaxis Trials: A Patient-Level Pooled Analysis.", "datePublished": "2022-08-27", "url": "https://questionsmedicales.fr/article/36145549", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/pharmaceutics14091801" } }, { "@type": "ScholarlyArticle", "name": "Risk and survival of patients with non-small cell lung cancer and pre-existing autoimmune disorders receiving immune checkpoint blockade therapy: Survival analysis with inverse probability weighting from a nationwide, multi-institutional, retrospective study (NEJ047).", "datePublished": "2024-07-14", "url": "https://questionsmedicales.fr/article/39029359", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.lungcan.2024.107894" } }, { "@type": "ScholarlyArticle", "name": "Mandibular dose-volume predicts time-to-osteoradionecrosis in an actuarial normal-tissue complication probability (NTCP) model: External validation of right-censored clinico-dosimetric and competing risk application across international multi-institutional observational cohorts and online graphical user interface clinical support tool assessment.", "datePublished": "2024-08-20", "url": "https://questionsmedicales.fr/article/39228724", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1101/2024.08.20.24312311" } }, { "@type": "ScholarlyArticle", "name": "The World Health Organization Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns (ACTION-III) Trial: study protocol for a multi-country, multi-centre, double-blind, three-arm, placebo-controlled, individually randomized trial of antenatal corticosteroids for women at high probability of late preterm birth in hospitals in low- resource countries.", "datePublished": "2024-04-12", "url": "https://questionsmedicales.fr/article/38609983", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13063-024-07941-0" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Système endocrine", "item": "https://questionsmedicales.fr/mesh/D004703" }, { "@type": "ListItem", "position": 3, "name": "Glandes endocrines", "item": "https://questionsmedicales.fr/mesh/D004702" }, { "@type": "ListItem", "position": 4, "name": "Gonades", "item": "https://questionsmedicales.fr/mesh/D006066" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Gonades - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Gonades", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Gonades", "description": "Comment diagnostiquer une dysfonction gonadique ?\nQuels examens pour évaluer la santé des gonades ?\nQuels signes indiquent une anomalie des gonades ?\nComment détecter un cancer des gonades ?\nQuel rôle joue l'échographie dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D006066?mesh_terms=Probability&page=278#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Gonades", "description": "Quels symptômes d'une insuffisance gonadique ?\nComment reconnaître un déséquilibre hormonal ?\nQuels signes d'inflammation des gonades ?\nQuels symptômes d'un cancer des gonades ?\nQuels symptômes d'une hyperplasie gonadique ?", "url": "https://questionsmedicales.fr/mesh/D006066?mesh_terms=Probability&page=278#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Gonades", "description": "Comment prévenir les maladies gonadiques ?\nQuel rôle des vaccinations dans la prévention ?\nComment éviter les infections gonadiques ?\nQuels examens réguliers pour la santé gonadique ?\nComment réduire le risque de cancer des gonades ?", "url": "https://questionsmedicales.fr/mesh/D006066?mesh_terms=Probability&page=278#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Gonades", "description": "Quels traitements pour l'insuffisance gonadique ?\nComment traiter un cancer des gonades ?\nQuelles options pour la dysfonction érectile ?\nComment gérer une hyperplasie gonadique ?\nQuels traitements pour les infections gonadiques ?", "url": "https://questionsmedicales.fr/mesh/D006066?mesh_terms=Probability&page=278#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Gonades", "description": "Quelles complications d'une insuffisance gonadique ?\nQuels risques liés à un cancer des gonades ?\nQuelles complications d'une hyperplasie gonadique ?\nQuels effets secondaires des traitements hormonaux ?\nQuelles complications des infections gonadiques ?", "url": "https://questionsmedicales.fr/mesh/D006066?mesh_terms=Probability&page=278#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Gonades", "description": "Quels facteurs de risque pour le cancer des gonades ?\nComment le mode de vie influence-t-il la santé gonadique ?\nQuels médicaments peuvent affecter les gonades ?\nQuel impact des infections sur la santé gonadique ?\nQuels facteurs environnementaux influencent les gonades ?", "url": "https://questionsmedicales.fr/mesh/D006066?mesh_terms=Probability&page=278#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction gonadique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic se fait par des tests hormonaux et des examens d'imagerie." } }, { "@type": "Question", "name": "Quels examens pour évaluer la santé des gonades ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses sanguines et des échographies peuvent être réalisées." } }, { "@type": "Question", "name": "Quels signes indiquent une anomalie des gonades ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des irrégularités menstruelles ou des problèmes de fertilité peuvent indiquer une anomalie." } }, { "@type": "Question", "name": "Comment détecter un cancer des gonades ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des examens d'imagerie et des marqueurs tumoraux sont utilisés pour le dépistage." } }, { "@type": "Question", "name": "Quel rôle joue l'échographie dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'échographie permet de visualiser les structures gonadiques et détecter des anomalies." } }, { "@type": "Question", "name": "Quels symptômes d'une insuffisance gonadique ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, troubles de la libido et irrégularités menstruelles sont fréquents." } }, { "@type": "Question", "name": "Comment reconnaître un déséquilibre hormonal ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des changements d'humeur, de poids et de libido peuvent signaler un déséquilibre." } }, { "@type": "Question", "name": "Quels signes d'inflammation des gonades ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Douleurs abdominales, fièvre et gonflement peuvent indiquer une inflammation." } }, { "@type": "Question", "name": "Quels symptômes d'un cancer des gonades ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des masses palpables, douleurs et changements dans les habitudes urinaires peuvent survenir." } }, { "@type": "Question", "name": "Quels symptômes d'une hyperplasie gonadique ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des menstruations irrégulières et des signes de virilisation peuvent être présents." } }, { "@type": "Question", "name": "Comment prévenir les maladies gonadiques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, une alimentation équilibrée et des examens réguliers aident." } }, { "@type": "Question", "name": "Quel rôle des vaccinations dans la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vaccinations, comme contre le HPV, peuvent prévenir des cancers gonadiques." } }, { "@type": "Question", "name": "Comment éviter les infections gonadiques ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Pratiquer des rapports protégés et éviter les partenaires multiples réduit le risque." } }, { "@type": "Question", "name": "Quels examens réguliers pour la santé gonadique ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des bilans hormonaux et des échographies peuvent être recommandés selon l'âge." } }, { "@type": "Question", "name": "Comment réduire le risque de cancer des gonades ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le tabac, maintenir un poids santé et se faire dépister régulièrement." } }, { "@type": "Question", "name": "Quels traitements pour l'insuffisance gonadique ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies hormonales substitutives sont souvent prescrites." } }, { "@type": "Question", "name": "Comment traiter un cancer des gonades ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Chirurgie, chimiothérapie et radiothérapie sont des options de traitement." } }, { "@type": "Question", "name": "Quelles options pour la dysfonction érectile ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments, des dispositifs ou des thérapies hormonales peuvent être utilisés." } }, { "@type": "Question", "name": "Comment gérer une hyperplasie gonadique ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments hormonaux et parfois une intervention chirurgicale sont nécessaires." } }, { "@type": "Question", "name": "Quels traitements pour les infections gonadiques ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des antibiotiques ou antiviraux sont prescrits selon l'infection." } }, { "@type": "Question", "name": "Quelles complications d'une insuffisance gonadique ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner des problèmes de fertilité et des troubles osseux." } }, { "@type": "Question", "name": "Quels risques liés à un cancer des gonades ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des métastases et des complications liées aux traitements peuvent survenir." } }, { "@type": "Question", "name": "Quelles complications d'une hyperplasie gonadique ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut causer des troubles menstruels et un risque accru de cancer." } }, { "@type": "Question", "name": "Quels effets secondaires des traitements hormonaux ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des changements d'humeur, des nausées et des risques thromboemboliques peuvent se produire." } }, { "@type": "Question", "name": "Quelles complications des infections gonadiques ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent entraîner des douleurs chroniques et des problèmes de fertilité." } }, { "@type": "Question", "name": "Quels facteurs de risque pour le cancer des gonades ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Antécédents familiaux, âge avancé et exposition à des substances cancérigènes augmentent le risque." } }, { "@type": "Question", "name": "Comment le mode de vie influence-t-il la santé gonadique ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme, l'obésité et le stress peuvent affecter la fonction gonadique." } }, { "@type": "Question", "name": "Quels médicaments peuvent affecter les gonades ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certains stéroïdes et médicaments anticancéreux peuvent altérer la fonction gonadique." } }, { "@type": "Question", "name": "Quel impact des infections sur la santé gonadique ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les infections sexuellement transmissibles peuvent endommager les gonades et affecter la fertilité." } }, { "@type": "Question", "name": "Quels facteurs environnementaux influencent les gonades ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "L'exposition à des produits chimiques et à des radiations peut nuire à la santé gonadique." } } ] } ] }

Sources (2774 au total)

Risk and survival of patients with non-small cell lung cancer and pre-existing autoimmune disorders receiving immune checkpoint blockade therapy: Survival analysis with inverse probability weighting from a nationwide, multi-institutional, retrospective study (NEJ047).

The risk and survival of patients with non-small cell lung cancer (NSCLC) with pre-existing autoimmune disorders (AIDs) receiving immune checkpoint blockade (ICB) therapy have not been clearly establi... This multi-institutional, retrospective cohort study was conducted in collaboration with 20 centers in Japan.... In total, 229 patients with advanced or recurrent NSCLC and pre-existing AID, with or without ICB treatment from January 2010-February 2020, were included and analyzed. Among 69 patients who received ... These findings revealed a novel risk factor for AID flares following ICB treatment, that is the diagnosis of NSCLC within 1 year of AID diagnosis, and showed that ICBs may improve survival in this pop...

Mandibular dose-volume predicts time-to-osteoradionecrosis in an actuarial normal-tissue complication probability (NTCP) model: External validation of right-censored clinico-dosimetric and competing risk application across international multi-institutional observational cohorts and online graphical user interface clinical support tool assessment.

Existing studies on osteoradionecrosis of the jaw (ORNJ) have primarily used cross-sectional data, assessing risk factors at a single time point. Determining the time-to-event profile of ORNJ has impo... Demographic, clinical and dosimetric data were retrospectively obtained for a clinical observational cohort of 1129 patients with HNC treated with radiotherapy (RT) at The University of Texas MD Ander... Our model identified that each unit increase in D25% is significantly associated with a 12% shorter time to ORNJ (Adjusted Time Ratio [ATR] 0·88, p<0·005); pre-RT dental extractions was associated to ... This study is the first to demonstrate a direct relationship between radiation dose and the time to ORNJ onset, providing a novel characterization of the impact of delivered dose not only on the proba... This work was supported by various funding sources including NIH, NIDCR, NCI, NAPT, NASA, BCM, Affirmed Pharma, CRUK, KWF Dutch Cancer Society, NWO ZonMw, and the Apache Corporation....

The World Health Organization Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns (ACTION-III) Trial: study protocol for a multi-country, multi-centre, double-blind, three-arm, placebo-controlled, individually randomized trial of antenatal corticosteroids for women at high probability of late preterm birth in hospitals in low- resource countries.

Preterm birth complications are the leading cause of newborn and under-5 mortality. Over 85% of all preterm births occur in the late preterm period, i.e. between 34 and < 37 weeks of gestation. Antena... WHO ACTION III trial is a parallel-group, three-arm, individually randomized, double-blind, placebo-controlled trial of two ACS regimens: dexamethasone phosphate 4 × 6 mg q12h or betamethasone phospha... This trial will evaluate the benefits and possible harms of ACS when used in women likely to have a late preterm birth. It will also evaluate a lower-dose ACS regimen based on literature from pharmaco... ISRCTN11434567 . Registered on 7 June 2021....